Editorial: Gliomas microenvironment: new drug entities, mechanisms of action, molecular biomarkers and drug delivery strategies

被引：0
|
作者：
Magalhaes, Mariana [1 ,2 ,3 ]
Matias, Diana [4 ]
Carbone, Claudia [5 ]
Cabral, Celia [2 ,3 ,6 ]
机构：
[1] Univ Coimbra, Inst Interdisciplinary Res IIIUC, Ctr Neurosci & Cell Biol CNC, Coimbra, Portugal
[2] Univ Coimbra, Coimbra Inst Clin & Biomed Res iCBR, Fac Med, Clin Acad Ctr Coimbra CACC, Coimbra, Portugal
[3] Univ Coimbra, Ctr Innovat Biomed & Biotechnol CIBB, Coimbra, Portugal
[4] Univ Lisbon, Fac Med, Inst Med Mol Joao Lobo Antunes, Lisbon, Portugal
[5] Univ Catania, Dept Drug & Hlth Sci, Catania, Italy
[6] Univ Coimbra, Ctr Funct Ecol, Dept Life Sci, Coimbra, Portugal
来源：
FRONTIERS IN PHARMACOLOGY | 2024年 / 15卷
关键词：
gliomas; glioblastoma; tumor microenvironment; drug repurposing; drug delivery; biomarkers; nanotechnology;
D O I：
10.3389/fphar.2024.1431975
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Novel insights into taxane pharmacology: An update on drug resistance mechanisms, immunomodulation and drug delivery strategies
    Beretta, Giovanni Luca
    Cassinelli, Giuliana
    Rossi, Giacomina
    Azzariti, Amalia
    Corbeau, Ileana
    Tosi, Diego
    Perego, Paola
    DRUG RESISTANCE UPDATES, 2025, 81
  • [32] A Quantitative Framework and Strategies for Management and Evaluation of Metabolic Drug-Drug Interactions in Oncology Drug DevelopmentNew Molecular Entities as Object Drugs
    Karthik Venkatakrishnan
    Michael D. Pickard
    Lisa L. von Moltke
    Clinical Pharmacokinetics, 2010, 49 : 703 - 727
  • [33] Drug-Induced Nephrotoxicity: Pathogenic Mechanisms, Biomarkers and Prevention Strategies
    Wu, Huizi
    Huang, Jiaguo
    CURRENT DRUG METABOLISM, 2018, 19 (07) : 559 - 567
  • [34] Editorial: Molecular mechanisms underlying pain relief and drug tolerance
    Krabichler, Quirin
    Reynders, Ana
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2023, 16
  • [35] New Modalities and Strategies in Drug Delivery and Discovery Foreword
    Ishida, Tatsuhiro
    Kogure, Kentaro
    Tachikawa, Masanori
    Baba, Kazuhiko
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2022, 70 (05) : 309 - 309
  • [36] Succinylcholine - New insights into mechanisms of action of an old drug
    Martyn, J
    Durieux, ME
    ANESTHESIOLOGY, 2006, 104 (04) : 633 - 634
  • [37] Nanoparticles:: Characteristics, mechanisms of action, and toxicity in pulmonary drug delivery -: A review
    Gill, Simardeep
    Lobenberg, Raimar
    Ku, Tabitha
    Azarmi, Shirzad
    Roa, Wilson
    Prenner, Elmar J.
    JOURNAL OF BIOMEDICAL NANOTECHNOLOGY, 2007, 3 (02) : 107 - 119
  • [38] CURRENT DATA ON THE EFFECTIVENESS OF GLICLAZIDE AND MOLECULAR MECHANISMS OF ACTION OF THE DRUG
    Petunina, Nina A.
    Kuzina, Irina A.
    Nedosugova, Ludmila, V
    DIABETES MELLITUS, 2020, 23 (04): : 357 - 367
  • [39] Luteolin as a potential hepatoprotective drug: Molecular mechanisms and treatment strategies
    Yao, Chenhao
    Dai, Shu
    Wang, Cheng
    Fu, Ke
    Wu, Rui
    Zhao, Xingtao
    Yao, Yuxin
    Li, Yunxia
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 167
  • [40] The antitumor mechanisms of glabridin and drug delivery strategies for enhancing its bioavailability
    Li, Chong
    Wang, Yu
    Zhang, Wenjing
    Yang, Xiaoman
    Wang, Yufang
    Hou, Guanqun
    Wang, Dongli
    Han, Bingbing
    Zhang, Yimin
    FRONTIERS IN ONCOLOGY, 2024, 14
12345